Rosemary Supplementation as an Adjunctive Therapy to SSRIs Reduces Anxiety and Depression Symptoms
Written by Taylor Woosley, Staff Writer. 8-week supplementation of rosemary (capsule containing rosmarinic acid amounts of 21.13 ± 0.56) significantly decreased BDI-II scores (p-value = 0.001) and HADS-A scores (p-value = 0.001) compared to the control group.





